Pulse Insurance is offering policyholders a combined screening and cancer navigation insurance product through Reframe Cancer.
The move follows the launch of the cancer product targeting young adults in August 2024 in partnership with both Pulse and Rokstone, the International Speciality (Re)Insurance MGA, part of the Aventum Group.
Pulse will now offer both group and individual policyholders Reframe Cancer’s Care Quality Commission (CQC) regulated screening product.
They will also have access to Reframe Cancer’s information hub and resource library.
Key features of the product at launch included:
- A lump sum pay-out upon first diagnosis for 95% of cancers
- Access to a personalised cancer care plan, providing support and guidance through both the NHS and private cancer pathways
- Tailored, emotional and practical support from a dedicated cancer nurse and cancer support manager
- Pre-diagnosis support to guide policyholders to make healthy lifestyle choices which may prevent cancer, as well as providing awareness of symptoms that could need investigating
Mark Stephenson, CEO of Reframe Cancer (pictured), said Pulse’s “forward thinking approach to cancer navigation and prevention builds on the launch of the cancer care product from last year.“
“I am delighted that they are the first insurance provider to market with our combined screening and cancer navigation insurance product. It is testament to the ethos and vision of Pulse that employees will also receive access to Reframe’s screening product and expert advice and guidance.”
Ben Broom, head of health at Pulse Insurance, added: “We believe that the combination of our specialist insurance expertise coupled with Reframe Cancer’s unique support and resources will enable groups and individuals to benefit not just from help if they are diagnosed with cancer but also to have easy access to screening right now – we know that cancer diagnosed at an early stage, is more likely to be treated successfully.
“Spotting cancer early really does save lives.”